Grace Harkin1, Áine Keogh1, Eoin Slattery1. Show Affiliations » 1. Department of Gastroenterology, University Hospital Galway, Galway, Ireland.
Abstract
Entities: Disease
Mesh： See more » Acute DiseaseAdalimumab/administration & dosageAdultBiosimilar Pharmaceuticals/administration & dosageBiosimilar Pharmaceuticals/adverse effectsColitis, Ulcerative/diagnosisColitis, Ulcerative/drug therapyColitis, Ulcerative/physiopathologyDrug MonitoringDrug Substitution/methodsFemaleGastrointestinal Agents/administration & dosageGastrointestinal Agents/adverse effectsHumansInfliximab/administration & dosageInfliximab/adverse effectsIrelandMaleSeverity of Illness IndexTreatment Outcome
Substances： See more » Biosimilar PharmaceuticalsGastrointestinal AgentsInfliximabAdalimumab
Year: 2017 PMID： 28444254 DOI： 10.1093/ecco-jcc/jjx059
Source DB: PubMed Journal: J Crohns Colitis ISSN： 1873-9946 Impact factor: 9.071